Ocular Therapeutix Stock (NASDAQ: OCUL) stock price, news, charts, stock research, profile.
You can purchase shares of Ocular Therapeutix (NASDAQ:OCUL) through any online brokerage.
Other companies in Ocular Therapeutix’s space includes: Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE), Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS) and Phibro Animal Health (NASDAQ:PAHC).
Ocular Therapeutix has a consensus price target of $15.38.
The stock price for Ocular Therapeutix (NASDAQ: OCUL) is $8.9 last updated October 1, 2024 at 4:07 PM EDT.
There are no upcoming dividends for Ocular Therapeutix.
Ocular Therapeutix’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Ocular Therapeutix.
Ocular Therapeutix is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.